BRAF and neoplasm: In metastatic melanoma, for example, the cooperation of CD8+ T cells and Natural Killer cells are necessary to mediate anti-tumor activity during combination therapy with IL2 and anti-CTLA [70], and for the use of BRAF inhibitors in metastatic melanoma [71].